| Ref number |
Authors |
Responsible candidates |
Study style |
| |
Year published |
|
|
| 15 |
Konaka A (1999) |
Enterobacterial translocation |
A |
| 2 |
Wallace JL ( 2012) |
enteropathy of enteric bacteria, and bile |
A |
| 16 |
Wallace JL ( 2011) |
PPIs exacerbate NSAID-induced intestinal damage |
A |
| 5 |
Wallace JL ( 2013) |
PPI can significantly worsen NSAID-induced damage in the small intestine |
A |
| 17 |
Takeuchi K (2010) |
COX-1 and COX-2 |
A |
| 18 |
Hotz-Behofsits C (2010) |
COX-2 |
A |
| 19 |
Tanaka A (1999) |
Nitric oxide derived by iNOS |
A |
| 20 |
Parasher G (2001) |
Nitric oxide |
A |
| 21 |
Xue B (2009) |
iNOS-dependent nitric oxide |
A |
| 22 |
Boelsterli UA (2013) |
Oxidative metabolites |
A |
| 23 |
Omatsu T (2009) |
Reactive oxygen species |
CL |
| 24 |
Matsui H (2011) |
mitochondrial oxidative phosphorylation |
A |
| 25 |
Satoh H (2009) |
Insoluble dietary fibre, intestinal hypermotility, leukotrienes and cholinergic pathways |
A |
| 26 |
Nandi J (2010) |
TNF-alpha |
A |
| 27 |
Shiotani A (2011) |
Combination of low-dose aspirin therapy and thienopyridine |
C |
| 28 |
Ramirez-Alcantara V (2009) |
JNK |
A |
| 29 |
Imaoka H (2010) |
Reg I |
A |
| 30 |
Kakimoto K (2010) |
MMP-9 |
A |
| 31 |
Kubo Y (2010) |
Urocortin 1(a nonselective CRF receptor agonist) |
A |
| 32 |
Yamada S (2011) |
IL-17A |
A |
| 33 |
Higashiyama M (2012) |
Enhanced platelets-bearing neutrophil migration |
A |
| 34 |
Nadatani Y (2012) |
HMGB1 |
A |
| 35 |
Kato S (2012) |
serotonin (5-HT) 3 receptors |
A |
| 36 |
Takagi T (2012) |
Hemopexin |
A |
Abbreviations